So sánh cơ cấu sử dụng tân dược sản xuất trong nước thuộc phạm vi thanh toán bảo hiểm y tế tại các bệnh viện công lập khi thực hiện thông tư số 10/2016/TT-BYT giai đoạn 2017 - 2019=Comparison of the structure using domestic modern pharmaceutical products within health insurance coverage in public hospitals in the implementation of circular 10/2016/tt-byt period 2017-2019

0 Người đánh giá. Xếp hạng trung bình 0

Tác giả: Xuân Thắng Đỗ, Thị Thuận Hoàng, Thị Hương Minh Ngô, Thị Thùy Linh Nguyễn, Minh Khuê Phạm, Đức Cảnh Vũ

Ngôn ngữ: vie

Ký hiệu phân loại:

Thông tin xuất bản: Y học cộng đồng, 2023

Mô tả vật lý: tr.198-204

Bộ sưu tập: Metadata

ID: 477725

Thêm vào giỏ

Compare the change in the number of drug items, and the value of domestic drug money accounted for during the implementation of Circular 10/2016/TT-BYT at Vietnamese public hospitals, period 2017 - 2019. Subjects and methods: Policy analysis research. The subject was the list of modern pharmaceuticals under the payment scope of the Health Insurance fund used at public hospitals 3 times in 2017, 2018, and 2019. Result: The value of domestic drug money accounted in Circula 10 in 2018 and 2019 was higher than in 2017 at all hospital lines as well as at each hospital level. The number of domestic drug items in Circular 10 in 2018 and 2019 increased compared to 2017 in groups 2, 3, and 4 generic, of which group 3 generic had the highest number of domestic drug items in Circular 10 in the 2017-2019 period. Conclusion: Circular 10 has had a specific impact in promoting substituting some foreign drugs with domestic ones that meet the treatment requirements, drug prices, and supply capacity.So sánh sự thay đổi về số khoản mục thuốc, giá trị tiền thuốc sử dụng đối với thuốc trong nước trong khi thực hiện Thông tư 10/2016/TT-BYT tại các bệnh viện công lập Việt Nam, giai đoạn 2017 - 2019. Đối tượng và phương pháp: Nghiên cứu phân tích chính sách. Đối tượng nghiên cứu là danh mục tân dược thuộc phạm vi thanh toán của quỹ Bảo hiểm y tế được sử dụng tại bệnh viện công lập tại 3 thời điểm năm 2017, 2018 và 2019. Kết quả: Giá trị tiền thuốc sử dụng đối với thuốc trong nước thuộc Thông tư 10 năm 2018, 2019 cao hơn năm 2017 tại tổng các tuyến bệnh viện cũng như tại từng tuyến bệnh viện. Số khoản mục thuốc trong nước thuộc TT10 tại năm 2018, 2019 tăng so với năm 2017 tại nhóm 2, 3 và 4 generic, trong đó nhóm 3 generic có số khoản mục thuốc trong nước thuộc Thông tư 10 cao nhất trong giai đoạn 2017 -2019. Kết luận: Thông tư 10 đã có hiệu quả nhất định trong việc tăng cường sử dụng thuốc trong nước đáp ứng được yêu cầu về điều trị, giá thuốc và khả năng cung cấp.

1. Đọc trực tuyến

1. Đọc trực tuyến

Tạo bộ sưu tập với mã QR